Alpha-ketoglutarate (AKG), a compound in food supplements, reduced kidney disease damage in mice by fixing damaged mitochondria, improving gut bacteria balance, and changing harmful body chemicals. According to Gram Research analysis of this 2026 study, AKG treatment decreased kidney inflammation and scarring while restoring healthy bacterial diversity in the gut. However, this research was conducted only in mice, so human clinical trials are needed before doctors can recommend AKG as a kidney disease treatment.
Researchers discovered that alpha-ketoglutarate (AKG), a compound found in food supplements, may help protect kidneys from chronic kidney disease in mice. According to Gram Research analysis, AKG worked by fixing damaged mitochondria (the energy centers of cells), improving gut bacteria balance, and changing harmful chemicals in the body. The study used advanced imaging and genetic testing to show how AKG reduced inflammation and scarring in diseased kidneys. While these results are promising, the research was done in mice, so scientists need to test whether it works safely in humans before recommending it as a treatment.
Key Statistics
A 2026 research study found that alpha-ketoglutarate treatment restored normal mitochondrial structure and function in mice with chronic kidney disease, reducing kidney inflammation and fibrotic scarring.
According to the 2026 research, AKG treatment increased beneficial Bacteroidetes bacteria while decreasing the harmful Firmicutes-to-Bacteroidetes ratio in mice with kidney disease, indicating improved gut health.
The 2026 study identified that AKG regulated 17 different metabolites (body chemicals) associated with chronic kidney disease, suggesting the supplement works through multiple protective pathways in the body.
The Quick Take
- What they studied: Whether a natural supplement called alpha-ketoglutarate (AKG) could help treat chronic kidney disease and how it might work in the body
- Who participated: Male laboratory mice were divided into groups: some ate a normal diet while others ate a diet designed to damage their kidneys. Half of each group received AKG treatment for 28 days while the other half received a placebo
- Key finding: AKG treatment reduced kidney damage, lowered inflammation, improved the health of mitochondria (cellular energy factories), and restored healthy gut bacteria balance in mice with kidney disease
- What it means for you: This research suggests AKG might become a helpful treatment for kidney disease, but it’s still in early stages. More testing in humans is needed before doctors can recommend it as a treatment. If you have kidney disease, talk to your doctor before taking any new supplements
The Research Details
Scientists used male laboratory mice to test whether AKG could help kidney disease. They divided the mice into four groups: some ate normal food while others ate a special diet that damages kidneys (mimicking human kidney disease). Within each diet group, half the mice received AKG mixed into their water while the other half received plain water as a control. All mice were treated for 28 days.
The researchers used several advanced tools to understand how AKG worked. They used electron microscopes to look at tiny structures inside kidney cells called mitochondria. They analyzed the bacteria living in the mice’s guts using genetic testing. They also measured hundreds of different chemicals in the mice’s bodies to see what changed with AKG treatment. Finally, they used computer analysis to connect all these findings together.
This research approach is important because it doesn’t just show whether AKG helps, it reveals the actual mechanisms, or pathways, by which it might work. By examining mitochondria, gut bacteria, and body chemicals all together, researchers can understand the complete picture of how AKG protects kidneys. This multi-layered approach makes the findings more meaningful and helps scientists design better human studies in the future.
This study has several strengths: it used multiple advanced testing methods, included control groups for comparison, and examined the problem from multiple angles (mitochondria, microbiota, and metabolites). However, the study was conducted only in mice, which limits how directly the results apply to humans. The sample size of mice wasn’t specified in the abstract. The research is recent (2026) and published in a peer-reviewed journal, which adds credibility. Readers should understand this is early-stage research that needs human testing before clinical use.
What the Results Show
AKG treatment significantly improved kidney function in mice with chronic kidney disease. The supplement reduced kidney inflammation and slowed the development of kidney scarring (fibrosis), which is a major problem in kidney disease progression.
Most importantly, AKG restored the health of mitochondria, the tiny structures that power cells. In kidney disease, mitochondria become damaged and misshapen. The electron microscope images showed that AKG treatment fixed these structural problems and restored normal mitochondrial function.
The supplement also dramatically improved the balance of gut bacteria. Specifically, AKG increased beneficial bacteria called Bacteroidetes while reducing harmful bacteria. The ratio of Firmicutes to Bacteroidetes, a key measure of gut health, improved significantly with treatment.
AKG treatment changed 17 different chemicals in the body that are associated with kidney disease, including compounds like aldosterone and n-acetylproline. These chemical changes suggest AKG works through multiple pathways in the body. The research also identified that AKG may work through a specific cellular communication pathway called the FAK-PI3K/Akt axis, which controls how cells respond to stress and injury. This finding helps explain why AKG has such broad protective effects.
Previous research has shown that AKG has anti-inflammatory and antioxidant properties, but this is the first study to comprehensively examine how it might help kidney disease. The finding that AKG works through three connected systems, mitochondrial health, gut bacteria, and body chemistry, is novel. This multi-system approach aligns with emerging understanding that kidney disease involves problems throughout the body, not just in the kidneys themselves.
The most important limitation is that this research was conducted in mice, not humans. Mouse studies don’t always translate to human medicine. The study didn’t specify the exact number of mice used or provide detailed statistical analysis in the abstract. The treatment period was only 28 days, so we don’t know if benefits continue longer or if side effects develop over time. The study used a specific type of kidney disease model in mice, which may not perfectly match all types of human kidney disease. Finally, the dose of AKG used (2%) was quite high and may not be practical or safe at that level in humans.
The Bottom Line
Based on this research, AKG shows promise as a potential kidney disease treatment, but it’s too early to recommend it for patients. The evidence is strong in mice (high confidence in the mouse model) but zero evidence exists in humans (very low confidence for human use). People with kidney disease should not start taking AKG supplements based on this study alone. Instead, wait for human clinical trials and consult your nephrologist (kidney doctor) before trying any new supplements.
This research is most relevant to: (1) kidney disease patients and their doctors who are looking for new treatment options, (2) pharmaceutical companies interested in developing new kidney disease medications, and (3) researchers studying how gut bacteria affects kidney health. People without kidney disease don’t need to change their behavior based on this study. People with kidney disease should discuss this research with their doctor rather than self-treating.
In mice, benefits appeared within 28 days of treatment. However, human studies typically take 2-5 years to complete and show safety and effectiveness. If human trials are started soon, it could be 5-10 years before AKG might become available as a kidney disease treatment. Don’t expect immediate results even if you could access AKG today, the research simply isn’t at that stage yet.
Frequently Asked Questions
Can I take alpha-ketoglutarate to treat my kidney disease?
Not yet based on current evidence. This 2026 study showed promising results in mice, but human clinical trials haven’t been conducted. Talk to your nephrologist before taking any new supplements, as some may harm kidney function.
How does alpha-ketoglutarate help kidneys?
According to the 2026 research, AKG works through three connected systems: it repairs damaged mitochondria (cellular energy centers), improves gut bacteria balance, and changes harmful chemicals in the body. These changes together reduce kidney inflammation and scarring.
When will alpha-ketoglutarate be available as a kidney disease treatment?
This is still 5-10 years away at minimum. The research is in early stages (mouse studies only). Human safety and effectiveness trials must be completed first, which typically takes several years before FDA approval.
Is alpha-ketoglutarate safe for people with kidney disease?
Safety in humans with kidney disease hasn’t been tested yet. While AKG is used in supplements, the high doses used in this mouse study (2%) may not be safe for humans. Always consult your doctor before starting supplements if you have kidney disease.
What is the connection between gut bacteria and kidney disease?
This 2026 study suggests gut bacteria significantly influence kidney health. AKG improved kidney function partly by restoring healthy bacterial balance, indicating the gut-kidney connection is important for disease progression and treatment.
Want to Apply This Research?
- If a user has kidney disease and their doctor approves AKG supplementation in the future, track weekly kidney function markers (creatinine levels and GFR if available), daily inflammation symptoms (fatigue, swelling), and gut health indicators (digestion quality, energy levels) using a simple 1-10 scale
- Once human studies confirm safety, users could log daily AKG supplement intake, record any side effects, and track kidney-related symptoms. The app could send reminders for consistent dosing and prompt weekly check-ins with kidney function markers from lab work
- Establish a baseline of current kidney function and symptoms, then track changes monthly. Compare trends over 3-6 months to see if supplementation correlates with improvement. Share tracked data with your nephrologist at regular appointments to inform treatment decisions
This research was conducted in laboratory mice and has not been tested in humans. Alpha-ketoglutarate is not currently approved as a treatment for chronic kidney disease. Do not start taking AKG supplements to treat kidney disease without consulting your nephrologist or kidney specialist. Some supplements can worsen kidney function. This article is for educational purposes only and should not replace professional medical advice. Always discuss new supplements with your healthcare provider, especially if you have kidney disease, take medications, or have other health conditions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
